This application is a competing renewal of the Dartmouth COBRE research program titled "Dartmouth Lung Biology Center for Molecular, Cellular and Translational Research." The proposal builds on nine years of COBRE-funded, research that have supported the development of new concepts and innovative model systems for studying the underlying mechanisms of lung disease and chronic airway infection, bringing us closer .to our 'goal of developing new therapeutics for these diseases. Lung disease is the third most frequent cause of death in the United States, claiming ~360,000 Americans annually. Tragically, millions more live with chronic lung diseases including asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF), and the number of patients is increasing at an alarming rate. Thus, a better understanding of the etiology of lung disease is required, as are new therapeutic approaches. With support from COBRE I and II (2003-preserit), our Center has grown dramatically, from 6 investigators in 2002 to 32 tenure-track investigators in 2012. Of our 32;faculty, 12 are physician-scientists recruited to the Center with COBRE support. Our faculty have developed |novel in vitro models to study host-pathogen interactions in CF;initiated an ambitious program to characterize !the CF respiratory microbiome and mycobiome and .thus develop more effective therapies for chronic, polymicrobial lung infections;and established an ambitious CF drug-discovery program. During the period of COBRE l/ll support, our group has published 1,007 papers, garnering editorial and Faculty of 1000 recognition. Our faculty have also obtained $ extramural research support and received national awards. Overall, with funding from COBRE l/ll we have developed an internationally recognized Center of Biomedical Research;|Excellence in Lung Biology with the overarching goals of elucidating the underlying mechanisms of chronic microbial infections of the lungs and developing new approaches to treat, these diseases. The goals of COBRE are to build upon our successes, establishing a free-standing Center arid developing paradigms directly relevant to CF and other major lung diseases, including COPD and asthma. This research will be supported by a Pilot Project Program and four Center-specific cores: (1) Education, Mentoring and Administration, (2) Host- , Pathogen Interaction, (3) Live-Cell Imaging and (4) Translational Research. In this section, we will describe . the Pilot Project Program (P3) and how it will support the Dartmouth Lung,Biolpgy Center (LBC).

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-TWD-C (C3))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Dartmouth College
United States
Zip Code
Amacher, Jeanine F; Zhao, Ruizhi; Spaller, Mark R et al. (2014) Chemically modified peptide scaffolds target the CFTR-associated ligand PDZ domain. PLoS One 9:e103650
Cheng, Shih-Chin; Quintin, Jessica; Cramer, Robert A et al. (2014) mTOR- and HIF-1?-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345:1250684
Chen, Annie I; Dolben, Emily F; Okegbe, Chinweike et al. (2014) Candida albicans ethanol stimulates Pseudomonas aeruginosa WspR-controlled biofilm formation as part of a cyclic relationship involving phenazines. PLoS Pathog 10:e1004480
Torres, Iviana M; Patankar, Yash R; Shabaneh, Tamer B et al. (2014) Acidosis potentiates the host proinflammatory interleukin-1? response to Pseudomonas aeruginosa infection. Infect Immun 82:4689-97
Chung, Dawoon; Barker, Bridget M; Carey, Charles C et al. (2014) ChIP-seq and in vivo transcriptome analyses of the Aspergillus fumigatus SREBP SrbA reveals a new regulator of the fungal hypoxia response and virulence. PLoS Pathog 10:e1004487
Chung, Dawoon; Thammahong, Arsa; Shepardson, Kelly M et al. (2014) Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus. Mol Microbiol 92:1279-98
Jackson, Angelyca A; Daniels, Emily F; Hammond, John H et al. (2014) Global regulator Anr represses PlcH phospholipase activity in Pseudomonas aeruginosa when oxygen is limiting. Microbiology 160:2215-25
Shepardson, Kelly M; Jhingran, Anupam; Caffrey, Alayna et al. (2014) Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infection. PLoS Pathog 10:e1004378